Загрузка...
PEGylation enables subcutaneously administered nanoparticles to induce antigen-specific immune tolerance
The development of nanomaterials to induce antigen-specific immune tolerance has shown promise for treating autoimmune diseases. While PEGylation has been widely used to reduce host immune responses to nanomaterials, its tolerogenic potential has not been reported. Here, we report for the first time...
Сохранить в:
| Опубликовано в: : | J Control Release |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7968989/ https://ncbi.nlm.nih.gov/pubmed/33450320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2021.01.013 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|